Press "Enter" to skip to content

New patent expiration for Gemini Labs drug OXANDRIN

0

Annual Drug Patent Expirations for OXANDRIN
Annual Drug Patent Expirations for OXANDRIN

Oxandrin is a drug marketed by Gemini Labs Llc
and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.

This drug has three patent family members in three countries.

The generic ingredient in OXANDRIN is oxandrolone. Additional details are available on the oxandrolone profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

    Do NOT follow this link or you will be banned from the site!